STTK
Shattuck LabsBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
+
Peers tracked
11
U.S. public peers
Grade Position
Above peers
vs peer average
STTK vs peer average
70/100
STTK vs. peer average (B vs. C)
Grade spread
A 1 · B 3 · C 2 · D 2 · F 3
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
SYRE is the first available peer comparator.
Spyre Therapeutics is the cleanest public pathway read-through because its IBD-focused pipeline includes anti-TL1A programs, but it is still not a direct valuation comp for STTK's DR3-blocking approach.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
STTK
Shattuck Labs
SYRE
Spyre Therapeutics
Grade
B
D
Momentum
98
96
Value
41
41
Sentiment
39
4
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Defensive
Grade position vs SYRE
STTK / SYRE
Grade Position
Above peers
STTK vs. peer average (B vs. C)
70/100
Momentum
98
STTKValue
41
STTKSentiment
39
STTKRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs STTK
SYRE is the first peer returned for this comparison set.